BIO CEO Program to highlight latest in clinical development.

Press Release Summary:



BIO announces Business Roundtables, Plenary Sessions, and Therapeutic Workshops selected for the 17th annual BIO CEO and Investor Conference, which will be held in New York City, February 9–10, 2015. Conference program will feature 5 Fireside Chats with leading biopharmaceutical executives and Wall Street analysts, each followed by interactive question and answer session. Program will highlight latest in clinical development, timely policy perspectives, and industry outlook for 2015.



Original Press Release:



17th Annual BIO CEO & Investor Conference to Feature Congressional Leaders, Institutional Investors, Industry Analysts and Senior Biotechnology Executives



BIO CEO Program to highlight latest in clinical development, timely policy perspectives and industry outlook for 2015

BIO CEO & Investor Conference 2015



WASHINGTON -- The Biotechnology Industry Organization (BIO) today announces Business Roundtables, Plenary Sessions and Therapeutic Workshops selected for the 17th annual BIO CEO & Investor Conference. The event, to be held in New York City, February 9-10, 2015, is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies.



“Following another banner year for biotech equity returns as well as the highest number of FDA new drug approvals in nearly two decades, investor interest in the biotech sector continues to grow”



“Following another banner year for biotech equity returns as well as the highest number of FDA new drug approvals in nearly two decades, investor interest in the biotech sector continues to grow,” said BIO President and CEO Jim Greenwood. “The BIO CEO & Investor Conference will be an excellent opportunity for attendees to hear from biotech, pharma and Wall Street leaders as they discuss the legislative, therapeutic and business catalysts driving positive industry activity as well as their expectations for 2015 and beyond.”



The conference program will feature five Fireside Chats with leading biopharmaceutical executives and Wall Street analysts, each followed by an interactive question and answer session.



Fireside Chats include:



Ian C. Read, Chairman of the Board and CEO, Pfizer

Tuesday, February 10, 3:30 – 4:25 pm



John F. Milligan, PhD, President and COO, Gilead Sciences

Tuesday, February 10, 10:00 – 10:55 am



John Maraganore, PhD, CEO, Alnylam

Tuesday, February 10, 11:00 – 11:55 am



Peter Greenleaf, CEO, Sucampo

Tuesday, February 10, 1:30 – 2:25 pm



Ron Cohen, MD, President & CEO, Acorda

Tuesday, February 10, 2:30 – 3:25 pm



Business Roundtables include:

Emerging Trends in Deal Structures

Monday, February 9, 9:30 – 10:25 am

Moderator: Effie Toshav, Partner, Fenwick & West



Panelists:

Bruce Booth, Partner, Atlas Venture

David H. Donabedian, PhD, Vice President, Head of Ventures & Early Stage Collaborations, AbbVie

C. Randall Mills, PhD, President and CEO, California Institute of Regenerative Medicine (CIRM)

Adelene Perkins, CEO, Infinity Pharmaceuticals

Mark Schoenebaum, MD, Senior Managing Director, Evercore ISI



How Industry Rates Interactions with the FDA: What is Working Well and What Needs to Improve?

Monday, February 9, 1:30 – 2:25 pm

Moderator: Cartier Esham, PhD, EVP Emerging Companies Section, BIO

Panelists:

Paul Hastings, Chairman and CEO, OncoMed Pharmaceuticals

Michael Narachi, President and CEO, Orexigen Therapeutics



Digital Health—Early Successes for Investors and Biotech R&D Productivity

Monday, February 9, 3:00 – 3:55 pm

Moderator: Matthew Hudes, U.S. Managing Principal, Biotechnology, Deloitte

Panelists:

Donald Jones, Co-Founder and Chairman, Wireless-Life Sciences Alliance; Chief Digital Officer of the Scripps Translational Science Institute

Julie Papanek, Principal, Canaan Partners

Ryan Pierce, Entrepreneur in Residence, Rock Health



Plenary Sessions include:

Producing "21st Century Cures"—2015 U.S. Legislative Outlook

Monday, February 9, 12:00 – 12:55 pm

Moderator: Jim Greenwood, President and CEO, BIO

Panelists:

Rep. Fred Upton, Chairman of Energy & Commerce Committee

Rep. Diana DeGette, Member of Energy & Commerce Committee



Following Venture Flow by Disease Indication—Past, Present, and Future Focus of VC Investment in Biotech

Tuesday, February 10, 12:00 – 12:55 pm

Moderator: Stephen B. Thau, Partner, Morrison Foerster

Panelists:

Roel Bulthuis, Vice President & Managing Director, MS Ventures

Jean-Francois Formela, MD, Partner, Atlas Venture

Robert Kiss, Managing Director, JP Morgan Investment Management

Jonathan Leff, Partner, Chairman of the Deerfield Institute, Deerfield

David Thomas, Director, Industry Research & Policy Analysis, BIO



“What’s Liquidity Got to Do With It?”—2015 Market Outlook

Tuesday, February 10, 4:30 – 5:25 pm

Moderator: Annette Grimaldi, Managing Director, Healthcare Life Sciences, BMO Capital Markets

Panelists:

Darren Carroll, SVP of Corporate Business Development, Eli Lilly and Company

John Chambers, Vice-Chairman and Head of Healthcare Investment Banking, Roth Capital Partners

Dennis J. Purcell, Founder and Senior Advisor, Aisling Capital

Mark Timney, President & CEO, Purdue Pharma



Therapeutic Workshops include:

Personalizing Oncology Treatments with Molecular Diagnostics

Monday, February 9, 8:00 – 8:55 am

Moderator: Michael King, Managing Director, Senior Research Analyst, JMP Securities

Panelists:

Arie Belldegrun, MD, FACS, Chairman, President & CEO, Kite Pharma

Jean C. Zenklusen, PhD, Director, The Cancer Genome Atlas, National Institutes of Health



Getting Ahead of Ebola and Other Infectious Threats—Overturning Assumptions

Monday, February 9, 11:00 – 11:55 am

Moderator: Phyllis Arthur, Senior Director, Vaccines, Immunotherapeutics & Diagnostics Policy, BIO

Panelists:

Ripley Ballou, MD, Head of Ebola Vaccine Research, GSK

Chris Garabedian, President & CEO, Sarepta Therapeutics

Peter Khoury, PhD, Senior Program Officer, Bill & Melinda Gates Foundation

Guillaume Leroy, PhD, Head of Dengue Vaccines, Sanofi Pasteur

Clifford J. Stocks, CEO, Theraclone Sciences



“Trust Your Gut”—Therapeutic Opportunities of the Microbiome

Tuesday, February 10, 8:00 – 8:55 am

Moderator: Mark Breidenbach, PhD, Equity Research Group, H.C. Wainwright & Co.

Panelists:

Karim Dabbagh, PhD, Chief Scientific Officer, Second Genome

Jeffrey Riley, CEO & President, Synthetic Biologics



To register now or learn more about the BIO CEO & Investor Conference, including program and partnering information, plus the names of more than 150 presenting companies, please visit here.



Complimentary investor registration is available for those who qualify. For information regarding qualified investor criteria and to apply for investor registration, please visit here.



Media registration is complimentary for credentialed members of the media. All registrations are subject to verification of credentials.



BIO is pleased to recognize the leadership provided by the BIO CEO & Investor Conference sponsors including Double Helix Sponsor Merck, Helix Sponsors Eli Lilly and Pfizer, and Supporting Bank Sponsors BMO Capital Markets, HC Wainwright & Co., JMP Securities, Lazard and ROTH Capital Partners, LLC.



About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.



Upcoming BIO Events



BIO CEO & Investor Conference

February 9-10, 2015

New York City, NY



BIO-Europe Spring

March 9-11, 2015

Paris, France



BIO Asia International Conference

March 24-25, 2015

Tokyo, Japan



BioEquity Europe

May 19-20, 2015

Vienna, Austria



BIO International Convention

June 15-18, 2015

Philadelphia, PA



Contacts

Biotechnology Industry Organization

Abigail Hirsch

202-962-9235

Web: www.bio.org

Blog: www.biotech-now.org

Twitter: @IAmBiotech

All Topics